menu search

PRFX / Why Is PainReform (PRFX) Stock Up 38% Today?

Why Is PainReform (PRFX) Stock Up 38% Today?
PainReform (NASDAQ: PRFX ) stock is rallying on Thursday after the pharmaceutical company regained compliance with Nasdaq listing requirements. According to the company's press release, it was sent notice of it regaining compliance on July 18. Read More
Posted: Jul 20 2023, 07:42
Author Name: InvestorPlace
Views: 112590

PRFX News  

Why Is PainReform (PRFX) Stock Up 38% Today?

By InvestorPlace
July 20, 2023

Why Is PainReform (PRFX) Stock Up 38% Today?

PainReform (NASDAQ: PRFX ) stock is rallying on Thursday after the pharmaceutical company regained compliance with Nasdaq listing requirements. Accor more_horizontal

PRFX Stock: The $2.7 Million Reason PainReform Is Up 100% Today

By InvestorPlace
July 14, 2023

PRFX Stock: The $2.7 Million Reason PainReform Is Up 100% Today

In the world of biotech stocks, one company that's generating big buzz today is PainReform (NASDAQ: PRFX ). The Israeli clinical-stage pharmaceutical more_horizontal

Why Is PainReform (PRFX) Stock Down 40% Today?

By InvestorPlace
July 12, 2023

Why Is PainReform (PRFX) Stock Down 40% Today?

PainReform (NASDAQ: PRFX ) stock is falling on Wednesday after the company announced a concurrent registered direct offering and private placement. Th more_horizontal

Why Is PainReform (PRFX) Stock Up 48% Today?

By InvestorPlace
February 8, 2023

Why Is PainReform (PRFX) Stock Up 48% Today?

PainReform (NASDAQ: PRFX ) stock is rocketing higher on Wednesday following an update on its delisting ordeal. A press release confirms that the compa more_horizontal

PainReform to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th

By GlobeNewsWire
March 21, 2022

PainReform to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th

TEL AVIV, Israel, March 21, 2022 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharma more_horizontal


Search within

Pages Search Results: